NovoCure

-$3.49 (-4.53%) Today
$0.00 (0.00%) As of 9:23 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NovoCure and other ETFs, options, and stocks.

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.

CEO
Asaf Danziger
Employees
1,167
Headquarters
St. Helier, Jersey
Founded
2000

NVCR Key Statistics

Market cap
7.70B
Price-Earnings ratio
—
Dividend yield
—
Average volume
639.25K
High today
$75.74
Low today
$72.49
Open price
$75.72
Volume
341.35K
52 Week high
$232.76
52 Week low
$56.51

NVCR Earnings

-$0.25
-$0.13
-$0.00
$0.12
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure